Zhang, C., Wang, X., Fang, D., Xu, P., Mo, X., Hu, C., . . . Xia, H. (2021). STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway. Theranostics.
Citação norma ChicagoZhang, Chengfei, et al. "STK39 Is a Novel Kinase Contributing to the Progression of Hepatocellular Carcinoma By the PLK1/ERK Signaling Pathway." Theranostics 2021.
Citação norma MLAZhang, Chengfei, et al. "STK39 Is a Novel Kinase Contributing to the Progression of Hepatocellular Carcinoma By the PLK1/ERK Signaling Pathway." Theranostics 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.